292 related articles for article (PubMed ID: 10435522)
21. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
22. Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model.
Lin YC; Hwang JJ; Wang SJ; Yang BH; Chang CW; Hsiao MC; Chou FI
Anticancer Res; 2012 Jul; 32(7):2657-64. PubMed ID: 22753723
[TBL] [Abstract][Full Text] [Related]
23. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
[TBL] [Abstract][Full Text] [Related]
25. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
[TBL] [Abstract][Full Text] [Related]
26. Studies on the structure of the complex of the boron neutron capture therapy drug, L-p-boronophenylalanine, with fructose and related carbohydrates: chemical and 13C NMR evidence for the beta-D-fructofuranose 2,3,6-(p-phenylalanylorthoboronate) structure.
Shull BK; Spielvogel DE; Head G; Gopalaswamy R; Sankar S; Devito K
J Pharm Sci; 2000 Feb; 89(2):215-22. PubMed ID: 10688750
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive quantitative in vivo mapping and metabolism of boronophenylalanine (BPA) by nuclear magnetic resonance (NMR) spectroscopy and imaging.
Bendel P; Margalit R; Koudinova N; Salomon Y
Radiat Res; 2005 Nov; 164(5):680-7. PubMed ID: 16238447
[TBL] [Abstract][Full Text] [Related]
28. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.
Coderre JA; Elowitz EH; Chadha M; Bergland R; Capala J; Joel DD; Liu HB; Slatkin DN; Chanana AD
J Neurooncol; 1997 May; 33(1-2):141-52. PubMed ID: 9151231
[TBL] [Abstract][Full Text] [Related]
29. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.
Hiramatsu R; Kawabata S; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake S; Kuroiwa T; Hao E; Vicente MG
J Pharm Sci; 2015 Mar; 104(3):962-70. PubMed ID: 25546823
[TBL] [Abstract][Full Text] [Related]
30. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
31. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
[TBL] [Abstract][Full Text] [Related]
32. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.
Liberman SJ; Dagrosa A; Jiménez Rebagliati RA; Bonomi MR; Roth BM; Turjanski L; Castiglia SI; González SJ; Menéndez PR; Cabrini R; Roberti MJ; Batistoni DA
Appl Radiat Isot; 2004 Nov; 61(5):1095-100. PubMed ID: 15308198
[TBL] [Abstract][Full Text] [Related]
33. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
34. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography.
Nichols TL; Kabalka GW; Miller LF; Khan MK; Smith GT
Med Phys; 2002 Oct; 29(10):2351-8. PubMed ID: 12408309
[TBL] [Abstract][Full Text] [Related]
35. Boronated dipeptide borotrimethylglycylphenylalanine as a potential boron carrier in boron neutron capture therapy for malignant brain tumors.
Takagaki M; Powell W; Sood A; Spielvogel BF; Hosmane NS; Kirihata M; Ono K; Masunaga SI; Kinashi Y; Miyatake SI; Hashimoto N
Radiat Res; 2001 Jul; 156(1):118-22. PubMed ID: 11418080
[TBL] [Abstract][Full Text] [Related]
36. Toward a clinical application of ex situ boron neutron capture therapy for lung tumors at the RA-3 reactor in Argentina.
Farías RO; Garabalino MA; Ferraris S; Santa María J; Rovati O; Lange F; Trivillin VA; Monti Hughes A; Pozzi EC; Thorp SI; Curotto P; Miller ME; Santa Cruz GA; Bortolussi S; Altieri S; Portu AM; Saint Martin G; Schwint AE; González SJ
Med Phys; 2015 Jul; 42(7):4161-73. PubMed ID: 26133616
[TBL] [Abstract][Full Text] [Related]
37. Multimodal evaluation of
Ciardiello A; Altieri S; Ballarini F; Bocci V; Bortolussi S; Cansolino L; Carlotti D; Ciocca M; Faccini R; Facoetti A; Ferrari C; Ficcadenti L; Furfaro E; Giagu S; Iacoangeli F; Macioce G; Mancini-Terracciano C; Messina A; Milazzo L; Pacifico S; Piccolella S; Postuma I; Rotili D; Vercesi V; Voena C; Vulcano F; Capuani S
Phys Med; 2022 Feb; 94():75-84. PubMed ID: 34999515
[TBL] [Abstract][Full Text] [Related]
38. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.
Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
Clin Cancer Res; 1998 Aug; 4(8):1825-32. PubMed ID: 9717808
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [
Watanabe T; Hattori Y; Ohta Y; Ishimura M; Nakagawa Y; Sanada Y; Tanaka H; Fukutani S; Masunaga SI; Hiraoka M; Ono K; Suzuki M; Kirihata M
BMC Cancer; 2016 Nov; 16(1):859. PubMed ID: 27821116
[TBL] [Abstract][Full Text] [Related]
40. 1H MRS of a boron neutron capture therapy 10B-carrier, L-p-boronophenylalanine-fructose complex, BPA-F: phantom studies at 1.5 and 3.0 T.
Heikkinen S; Kangasmäki A; Timonen M; Kankaanranta L; Häkkinen AM; Lundbom N; Vähätalo J; Savolainen S
Phys Med Biol; 2003 Apr; 48(8):1027-39. PubMed ID: 12741499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
